Scout Investments Inc. trimmed its holdings in Omnicell, Inc. (NASDAQ:OMCL) by 3.3% in the third quarter, according to its most recent disclosure with the SEC. The fund owned 151,750 shares of the company’s stock after selling 5,225 shares during the period. Scout Investments Inc. owned 405,206.94% of Omnicell worth $7,747,000 at the end of the most recent reporting period.
Several other institutional investors have also recently modified their holdings of OMCL. BlackRock Inc. increased its stake in shares of Omnicell by 139,475.2% during the first quarter. BlackRock Inc. now owns 4,487,343 shares of the company’s stock worth $182,412,000 after acquiring an additional 4,484,128 shares during the period. Janus Henderson Group PLC increased its stake in shares of Omnicell by 129.6% during the second quarter. Janus Henderson Group PLC now owns 1,231,933 shares of the company’s stock worth $53,096,000 after acquiring an additional 695,334 shares during the period. Principal Financial Group Inc. increased its stake in shares of Omnicell by 124.9% during the second quarter. Principal Financial Group Inc. now owns 660,803 shares of the company’s stock worth $28,481,000 after acquiring an additional 367,019 shares during the period. First Light Asset Management LLC increased its stake in shares of Omnicell by 108.0% during the second quarter. First Light Asset Management LLC now owns 278,294 shares of the company’s stock worth $11,994,000 after acquiring an additional 144,471 shares during the period. Finally, Russell Investments Group Ltd. increased its stake in shares of Omnicell by 70.2% during the second quarter. Russell Investments Group Ltd. now owns 347,914 shares of the company’s stock worth $14,995,000 after acquiring an additional 143,474 shares during the period.
A number of research analysts have recently issued reports on the stock. Dougherty & Co boosted their price target on shares of Omnicell from $45.00 to $49.00 and gave the stock a “buy” rating in a research note on Friday, July 28th. Craig Hallum boosted their price target on shares of Omnicell from $46.00 to $52.00 and gave the stock a “buy” rating in a research note on Friday, July 28th. BidaskClub lowered shares of Omnicell from a “strong-buy” rating to a “buy” rating in a research note on Monday, July 31st. Cantor Fitzgerald reiterated a “buy” rating and set a $47.00 price target on shares of Omnicell in a research note on Tuesday, July 25th. Finally, Piper Jaffray Companies reiterated a “hold” rating and set a $40.00 price target on shares of Omnicell in a research note on Sunday, July 30th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and seven have issued a buy rating to the stock. The company has a consensus rating of “Buy” and a consensus target price of $54.86.
TRADEMARK VIOLATION WARNING: “Scout Investments Inc. Trims Stake in Omnicell, Inc. (OMCL)” was reported by Markets Daily and is the sole property of of Markets Daily. If you are viewing this report on another site, it was illegally copied and republished in violation of US and international copyright and trademark legislation. The correct version of this report can be viewed at https://www.themarketsdaily.com/2017/11/12/scout-investments-inc-trims-stake-in-omnicell-inc-omcl.html.
In other Omnicell news, VP Jorge R. Taborga sold 6,295 shares of the company’s stock in a transaction dated Monday, November 6th. The shares were sold at an average price of $48.69, for a total transaction of $306,503.55. Following the transaction, the vice president now directly owns 50,013 shares in the company, valued at $2,435,132.97. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Chairman Randall A. Lipps sold 10,625 shares of the company’s stock in a transaction dated Friday, September 1st. The stock was sold at an average price of $52.00, for a total transaction of $552,500.00. The disclosure for this sale can be found here. Insiders have sold 62,741 shares of company stock worth $3,139,399 over the last 90 days. 3.77% of the stock is currently owned by company insiders.
Omnicell, Inc. (OMCL) opened at $46.40 on Friday. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.53 and a quick ratio of 1.08. Omnicell, Inc. has a 1 year low of $31.50 and a 1 year high of $55.40.
Omnicell (NASDAQ:OMCL) last issued its earnings results on Thursday, October 26th. The company reported $0.42 earnings per share for the quarter, hitting the consensus estimate of $0.42. Omnicell had a negative net margin of 0.51% and a negative return on equity of 0.79%. The company had revenue of $186.78 million for the quarter, compared to analyst estimates of $192.45 million. During the same period in the prior year, the business posted $0.40 earnings per share. The firm’s revenue for the quarter was up 5.7% compared to the same quarter last year. analysts forecast that Omnicell, Inc. will post 0.12 earnings per share for the current year.
Omnicell, Inc provides automation and business analytics software solutions for patient-centric medication and supply management across the entire healthcare continuum, from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home. It operates through two segments: Automation and Analytics, and Medication Adherence.
Want to see what other hedge funds are holding OMCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Omnicell, Inc. (NASDAQ:OMCL).
Receive News & Ratings for Omnicell Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omnicell Inc. and related companies with MarketBeat.com's FREE daily email newsletter.